Stockreport

Is There An Opportunity With ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 37% Undervaluation? [Yahoo! Finance]

ProQR Therapeutics N.V. - Ordinary Shares  (PRQR) 
Last proqr therapeutics n.v. - ordinary shares earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: proqr.com
PDF ProQR Therapeutics is estimated to be 37% undervalued based on current share price of US$2.59 The €8.00 analyst price target for PRQR is 94% more than our estimate of [Read more]